OBJECTIVES:
鈥� Provide information on the role of the Qualified Person (QP) in the global context.
鈥� Inform delegates about the MHRA risk-based inspection programme.
鈥� Provide delegates with an overview on human error factors, low-cost countries and the role of the
pharmacovigilance QP.
鈥� Update delegates on legislation.
鈥� Allow delegates to network with other QPs.
鈥� Contribute towards Continuing Professional Development.
Continuing Professional Development for Qualified Persons
Attendance at this seminar will contribute towards keeping your knowledge and experience up to date in the light of technical and scientific progress and changes in quality management relevant to the products which you are required to certify. This is now included in Annex 16 of the EC Guide to Good Manufacturing Practice.
鈥� Provide information on the role of the Qualified Person (QP) in the global context.
鈥� Inform delegates about the MHRA risk-based inspection programme.
鈥� Provide delegates with an overview on human error factors, low-cost countries and the role of the
pharmacovigilance QP.
鈥� Update delegates on legislation.
鈥� Allow delegates to network with other QPs.
鈥� Contribute towards Continuing Professional Development.
Continuing Professional Development for Qualified Persons
Attendance at this seminar will contribute towards keeping your knowledge and experience up to date in the light of technical and scientific progress and changes in quality management relevant to the products which you are required to certify. This is now included in Annex 16 of the EC Guide to Good Manufacturing Practice.
